45.72 +0.09 (0.20%)
ABT
| Trade ABT now with |
Stock Details
Last Trade:45.72 Change:+0.09 (0.20%) Prev Close:45.63 Open: 45.77 Days Range:45.51 – 45.84 52 Week Range: 36.00 - 46.38 Volume:6105876 P/E: 30.48EPS:1.50
View AllRecent Alerts 03/11/17
Recent Alert on 03/09/17 at 7:37am
Abbott Labs (ABT) PT Raised to $52 at Jefferies
Abbott Labs (ABT) PT Raised to $52 at Jefferies
Jefferies raised its price target on Abbott Labs (NYSE: ABT) to $52.00 (from $51.00) while maintaining a Buy rating.
Recent Alert on 02/12/17 at 3:09pm
Abbott Laboratories may see boost from St. Jude's acquisition: Barron's
Abbott Laboratories may see boost from St. Jude's acquisition: Barron's
Recent Alert on 02/06/17 at 3:03pm
Abiomed (ABMD) Gains Tied to Pause in Abbott's (ABT) Shield 2 Trial Enrollment
Abiomed (ABMD) Gains Tied to Pause in Abbott's (ABT) Shield 2 Trial Enrollment
Recent Alert on 02/02/17 at 8:02am
Abbott (ABT) Announces FDA Grants First Commercial Authorization for Molecular Test to Detect Zika Virus Using Whole Blood
Abbott (ABT) Announces FDA Grants First Commercial Authorization for Molecular Test to Detect Zika Virus Using Whole Blood
View AllRecent Press Releases
Press Release on 03/08/17 at 4:15pm
Abbott to Present at Barclays Capital 2017 Global Healthcare Conference
Abbott to Present at Barclays Capital 2017 Global Healthcare Conference
Press Release on 03/08/17 at 9:00am
New Study Results May Lead to a New Standard of Care for In Vitro Fertilization Treatment
New Study Results May Lead to a New Standard of Care for In Vitro Fertilization Treatment
Press Release on 03/07/17 at 9:00am
Abbott Announces Results of Early Tenders and Consents in Exchange Offers and Execution of Supplemental Indenture
Abbott Announces Results of Early Tenders and Consents in Exchange Offers and Execution of Supplemental Indenture